Aroa Biosurgery Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aroa Biosurgery
- Aroa secures FDA clearance for new product
- S&P DJI Announces March 2021 Quarterly Rebalance
- Aroa Half Year Results
- Aroa Biosurgery Secures FDA Clearance for Symphony
- European Approval Received for Myriad
Later from Aroa Biosurgery
- FY21 Full Year Results Presentation
- Trading Halt
- Aroa Completes $47m Placement and Launches $5m SPP
- Investor Presentation
- Aroa delivers strong half, Myriad GPO win
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery